Johnson & Johnson (JNJ) Return on Sales (2009 - 2026)

Johnson & Johnson has disclosed Return on Sales across 18 years of filings, most recently posting 0.0% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2023 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Sales came in at 0.0% for Q1 2026 at Johnson & Johnson, up from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2023 to a low of 0.0% in Q3 2023.
• The 5-year median for Return on Sales is 0.0% (2025), against an average of 0.0%.
• Across the five-year window, Return on Sales grew 1 bps in 2023 and fell 1 bps in 2024, its largest moves.
• Johnson & Johnson's Return on Sales stood at 0.0% in 2022, then sank by 152 bps to 0.0% in 2023, then jumped by 76 bps to 0.0% in 2024, then soared by 22106 bps to 0.0% in 2025, then advanced by 4 bps to 0.0% in 2026.
• The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.